Cargando…
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
BACKGROUND: Kidney transplant recipients (KTR) are at increased risk of cancer due to chronic immunosuppression. Non-melanoma skin cancer has an excess risk of approximately 250 times higher than the general population. Moreover, in solid organ transplant recipients (SOTR) these cancers have a more...
Autores principales: | Van Meerhaeghe, T., Baurain, J.F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., Aspeslagh, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479765/ https://www.ncbi.nlm.nih.gov/pubmed/37675002 http://dx.doi.org/10.3389/fneph.2022.1041819 |
Ejemplares similares
-
Kidney Transplant Outcomes in Recipients Over the Age of 70
por: Mehta, Jaya, et al.
Publicado: (2023) -
Immune monitoring of allograft status in kidney transplant recipients
por: Han, Hwarang S., et al.
Publicado: (2023) -
Thrombosis Associated With Cytomegalovirus (CMV) in a Kidney Transplant Recipient
por: Wang, Lin, et al.
Publicado: (2021) -
Screening of cognitive performance in kidney transplant recipients: a mini review
por: Schietzel, Simeon, et al.
Publicado: (2023) -
Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients
por: Pham, Phuong-Thu T., et al.
Publicado: (2022)